Boothbay Fund Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $431K | Buy |
+20,000
| New | +$431K | 0.01% | 787 |
|
|
2025
Q1 | – | Hold |
0
| – | – | – | 1186 |
|
|
2024
Q4 | – | Sell |
-17,157
| Closed | -$264K | – | 1280 |
|
|
2024
Q3 | $264K | Buy |
+17,157
| New | +$264K | 0.01% | 1124 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 1312 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 1358 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 1446 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 1482 |
|
|
2023
Q2 | – | Sell |
-12,856
| Closed | -$242K | – | 1512 |
|
|
2023
Q1 | $242K | Sell |
12,856
-45,253
| -78% | -$852K | 0.01% | 1405 |
|
|
2022
Q4 | $925K | Hold |
58,109
| – | – | 0.02% | 766 |
|
|
2022
Q3 | $951K | Buy |
+58,109
| New | +$951K | 0.02% | 791 |
|
|
2021
Q4 | – | Sell |
-28,434
| Closed | -$472K | – | 1647 |
|
|
2021
Q3 | $472K | Sell |
28,434
-7,193
| -20% | -$119K | 0.01% | 922 |
|
|
2021
Q2 | $869K | Buy |
35,627
+18,225
| +105% | +$445K | 0.03% | 662 |
|
|
2021
Q1 | $449K | Buy |
17,402
+11,621
| +201% | +$300K | 0.02% | 802 |
|
|
2020
Q4 | $309K | Sell |
5,781
-891
| -13% | -$47.6K | 0.01% | 787 |
|
|
2020
Q3 | $275K | Buy |
+6,672
| New | +$275K | 0.02% | 713 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 812 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 725 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 723 |
|
|
2018
Q4 | – | Sell |
-14,893
| Closed | -$309K | – | 557 |
|
|
2018
Q3 | $309K | Buy |
+14,893
| New | +$309K | 0.03% | 387 |
|